Ultragenyx Pharmaceutical (RARE) Selling, General & Administrative (2013 - 2026)
Ultragenyx Pharmaceutical (RARE) Selling, General & Administrative (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 17.02 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 1.32 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -37.00 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -1.52 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 2.17 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 217,225.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 493.70 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -7.36 Mn |
| 10 | Ultragenyx Pharmaceutical | 2.77 Bn | 2.36 Bn | 106.00 Mn | 88.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 88.00 Mn |
| Dec 31, 2025 | 87.94 Mn |
| Sep 30, 2025 | 86.62 Mn |
| Jun 30, 2025 | 86.65 Mn |
| Mar 31, 2025 | 87.00 Mn |
| Dec 31, 2024 | 81.89 Mn |
| Sep 30, 2024 | 80.35 Mn |
| Jun 30, 2024 | 80.60 Mn |
| Mar 31, 2024 | 78.16 Mn |
| Dec 31, 2023 | 77.03 Mn |
| Sep 30, 2023 | 74.92 Mn |
| Jun 30, 2023 | 81.40 Mn |
| Mar 31, 2023 | 76.65 Mn |
| Dec 31, 2022 | 72.85 Mn |
| Sep 30, 2022 | 69.84 Mn |
| Jun 30, 2022 | 68.14 Mn |
| Mar 31, 2022 | 67.31 Mn |
| Dec 31, 2021 | 59.43 Mn |
| Sep 30, 2021 | 53.88 Mn |
| Jun 30, 2021 | 53.41 Mn |